Literature DB >> 2673242

Stimulation of fibroblast proliferation by thrombospondin.

S H Phan1, R G Dillon, B M McGarry, V M Dixit.   

Abstract

Thrombospondin purified from human platelets was examined for its ability to promote proliferation of human dermal fibroblasts. The results show that thrombospondin could stimulate the incorporation of [3H]thymidine by quiescent fibroblasts in a dose-dependent manner without stimulating protein or collagen synthesis. The effect was observed even in the total absence of serum, although the degree of stimulation was substantially lower than that in the presence of 0.4% fetal calf serum, but higher than that in the presence of 4% serum. The effect was specific and not due to contaminants as demonstrated by the ability of antibodies to thrombospondin to specifically inhibit this stimulation. Three monoclonal antibodies directed at different epitopes in the thrombospondin molecule were equally effective in inhibiting this effect. This stimulation of fibroblast proliferation by thrombospondin suggests a potential role for this matrix protein in the mesenchymal cell response in tissue injury and repair.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673242     DOI: 10.1016/0006-291x(89)92098-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Transforming growth factor-beta complexes with thrombospondin.

Authors:  J E Murphy-Ullrich; S Schultz-Cherry; M Höök
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

2.  Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro.

Authors:  M L Iruela-Arispe; P Bornstein; H Sage
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

3.  Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice.

Authors:  M Streit; P Velasco; L Riccardi; L Spencer; L F Brown; L Janes; B Lange-Asschenfeldt; K Yano; T Hawighorst; L Iruela-Arispe; M Detmar
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

4.  Expression of thrombospondin-1 in ischemia-induced retinal neovascularization.

Authors:  K Suzuma; H Takagi; A Otani; H Oh; Y Honda
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

5.  Binding and degradation of thrombospondin-1 mediated through heparan sulphate proteoglycans and low-density-lipoprotein receptor-related protein: localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1.

Authors:  H Chen; J Sottile; D K Strickland; D F Mosher
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

6.  Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1.

Authors:  M J Reed; L Iruela-Arispe; E R O'Brien; T Truong; T LaBell; P Bornstein; E H Sage
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

7.  Thrombospondin-1 expression and localization in the developing ovine lung.

Authors:  Foula Sozo; Stuart B Hooper; Megan J Wallace
Journal:  J Physiol       Date:  2007-08-16       Impact factor: 5.182

8.  Interaction of thrombospondin with platelet glycoproteins GPIa-IIa and GPIIb-IIIa.

Authors:  M A Kowalska; G P Tuszynski
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

9.  Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism.

Authors:  S Schultz-Cherry; J E Murphy-Ullrich
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

10.  Matrix-bound thrombospondin promotes angiogenesis in vitro.

Authors:  R F Nicosia; G P Tuszynski
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.